Certolizumab Pegol for the Treatment of Patients with Moderate ‐to‐Severe Chronic Plaque Psoriasis: Pooled Analysis of Week 16 Data from 3 Randomized Controlled Trials

Journal of the European Academy of Dermatology and Venereology,Volume 0, Issue ja, -Not available-.

Source: Journal of the European Academy of Dermatology and Venereology - September 22, 2018 Category: Dermatology Authors: A. Blauvelt, K. Reich, M. Lebwohl, D. Burge, C. Arendt, L. Peterson, J. Drew, R. Rolleri, A. B. Gottlieb Source Type: research